Latest News

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Viva Leisure Limited's ( ASX:VVA ) price-to-earnings (or "P/E") ratio of 26.9x might make it look like a sell right now...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...

China East Education Holdings Limited ( HKG:667 ) shareholders have seen the share price descend 17% over the month...

Key Insights Mobvista's estimated fair value is HK$30.52 based on 2 Stage Free Cash Flow to Equity Current share price...

Shankar Lal Rampal Dye-Chem (NSE:SRD) has had a rough three months with its share price down 21%. However, the...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Key Insights The considerable ownership by retail investors in 17LIVE Group indicates that they collectively have a...

Key Insights Country Garden Services Holdings' estimated fair value is HK$8.40 based on 2 Stage Free Cash Flow to...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...

It hasn't been the best quarter for Tara Chand Infralogistic Solutions Limited ( NSE:TARACHAND ) shareholders, since...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

AV Promotions Holdings Limited ( HKG:8419 ) shareholders would be excited to see that the share price has had a great...

With a price-to-earnings (or "P/E") ratio of 16.3x Reliable Data Services Limited ( NSE:RELIABLE ) may be sending...

With its stock down 16% over the past week, it is easy to disregard D. P. Abhushan (NSE:DPABHUSHAN). But if you pay...

Procter & Gamble (NYSE:PG) is acquiring Wonderbelly, a "free from" digestive wellness brand, to broaden its Personal Health Care lineup. The deal adds a clean label, consumer focused product range to P&G's portfolio in the digestive health category. Procter & Gamble, trading at around $149.9 per share, is extending its reach further into consumer health with Wonderbelly. The company brings this new brand into a portfolio that has seen returns of 13.8% over 3 years and 31.8% over 5 years,...

Jeyyam Global Foods (NSE:JEYYAM) has had a rough three months with its share price down 36%. However, stock prices are...

If you have been wondering whether Robert Half's recent share price puts it in the bargain bin or the too hard basket, looking closely at what the current valuation suggests can help frame that decision. The stock last closed at US$27.09, with returns of a 5.5% decline over 7 days, a 1.5% decline over 30 days, a 0.9% decline year to date, a 55.5% decline over 1 year and a 65.7% decline over 3 years. These figures will shape how investors think about its future risk and reward trade...

Bankwell Financial Group (BWFG) has just wrapped up FY 2025 with fourth quarter revenue of US$29.7 million and EPS of about US$1.18, capping a trailing twelve month run that saw revenue reach US$107.3 million and EPS of roughly US$4.54. Over that period, revenue moved from US$64.4 million on a trailing basis in Q4 2024 to US$107.3 million in Q4 2025, while EPS on the same basis went from about US$1.24 to US$4.54. This puts the focus on how those earnings are translating into sustained margins...

Corcept Therapeutics recently reported that its pivotal Phase 3 ROSELLA trial showed relacorilant plus nab-paclitaxel improved both overall and progression-free survival in patients with platinum-resistant ovarian cancer, while maintaining a safety profile comparable to chemotherapy alone. An important insight is that relacorilant delivered a clinically meaningful 4.1‑month median overall survival benefit without adding to patients’ treatment-related side effects. Next, we’ll examine how...

When you see that almost half of the companies in the Healthcare industry in Hong Kong have price-to-sales ratios (or...

Exco Technologies (TSX:XTC) opened Q1 2026 with total revenue of $149.5 million, Basic EPS of $0.13 and net income of $4.8 million, setting the tone for how its auto components operations are currently translating into earnings power. The company has seen quarterly revenue move from $143.6 million and EPS of $0.11 in Q1 2025 to a range between $149.5 million and $166.1 million and EPS between $0.13 and $0.22 over the most recent five quarters, while trailing twelve month EPS sits at $0.65 on...